Given the importance of AQP4 in the glymphatic system, controlling its localization may lead to improved CSF drainage and could be a potential target for treating patients with TBI, post-SAH hydrocephalus, and NPH. The gene discussed is AQP4; the disease is normal pressure hydrocephalus.